{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:41:18Z","timestamp":1789990878830,"version":"4.0.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003529","name":"European Union","doi-asserted-by":"publisher","award":["FP7 project 242210 FIGHT-MG"],"award-info":[{"award-number":["FP7 project 242210 FIGHT-MG"]}],"id":[{"id":"10.13039\/501100003529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Swedish Society for Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007393","name":"Association Francaise contre les Myopathies","doi-asserted-by":"publisher","award":["WAR09-19"],"award-info":[{"award-number":["WAR09-19"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"name":"JSPS KAKENHI","award":["25670437"],"award-info":[{"award-number":["25670437"]}]},{"name":"JSPS KAKENHI","award":["24390228"],"award-info":[{"award-number":["24390228"]}]},{"name":"Health Labor Research","award":["H25-Aging-General-004"],"award-info":[{"award-number":["H25-Aging-General-004"]}]},{"DOI":"10.13039\/100004952","name":"MDA","doi-asserted-by":"publisher","award":["MDA217696"],"award-info":[{"award-number":["MDA217696"]}],"id":[{"id":"10.13039\/100004952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004952","name":"MDA","doi-asserted-by":"publisher","award":["MDA4172"],"award-info":[{"award-number":["MDA4172"]}],"id":[{"id":"10.13039\/100004952","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MGFI"},{"DOI":"10.13039\/100007393","name":"AFM","doi-asserted-by":"publisher","award":["14473"],"award-info":[{"award-number":["14473"]}],"id":[{"id":"10.13039\/100007393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["570930"],"award-info":[{"award-number":["570930"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Netherlands Organization for Scientific Research","award":["916.10.148"],"award-info":[{"award-number":["916.10.148"]}]},{"name":"Brain Foundation of the Netherlands","award":["FS2008(1)-28"],"award-info":[{"award-number":["FS2008(1)-28"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.expneurol.2014.12.013","type":"journal-article","created":{"date-parts":[[2014,12,24]],"date-time":"2014-12-24T12:00:39Z","timestamp":1419422439000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis"],"prefix":"10.1016","volume":"270","author":[{"given":"W.D.","family":"Phillips","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Christadoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Losen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Punga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Shigemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4572-1501","authenticated-orcid":false,"given":"J.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2014.12.013_bb0005","series-title":"Power Analysis for Experimental Research","author":"Bausell","year":"2002"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0010","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1126\/science.1130837","article-title":"Dok-7 mutations underlie a neuromuscular junction synaptopathy","volume":"313","author":"Beeson","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","article-title":"MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2 cultures and mouse muscle in vivo","volume":"170","author":"Benveniste","year":"2005","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0020","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.molcel.2010.06.007","article-title":"The cytoplasmic adaptor protein Dok7 activates the receptor tyrosine kinase MuSK via dimerization","volume":"39","author":"Bergamin","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","article-title":"Major pathogenic effects of anti-MuSK antibodies in Myasthenia Gravis","volume":"177","author":"Boneva","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0030","doi-asserted-by":"crossref","first-page":"11468","DOI":"10.1523\/JNEUROSCI.2508-08.2008","article-title":"Identification of a motif in the acetylcholine receptor \u03b2-subunit whose phosphorylation regulates rapsyn association and postsynaptic receptor localization","volume":"28","author":"Borges","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0035","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/mus.880171208","article-title":"Passive transfer of seronegative myasthenia gravis to mice","volume":"17","author":"Burges","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0040","author":"Center for Drug Evaluation and Research"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0045","doi-asserted-by":"crossref","first-page":"e67970","DOI":"10.1371\/journal.pone.0067970","article-title":"Sequence of age-associated changes to the mouse neuromuscular junction and the protective effects of voluntary exercise","volume":"8","author":"Cheng","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0050","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1093\/hmg\/ddh333","article-title":"MUSK, a new target for mutations causing congenital myasthenic syndrome","volume":"13","author":"Chevessier","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2011.12.016","article-title":"Neurophysiological characteristics of MuSK antibody positive Myasthenia Gravis mice: focal denervation and hypersensitivity to acetylcholinesterase inhibitors","volume":"316","author":"Chroni","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0060","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.21371","article-title":"Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction","volume":"63","author":"Cole","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0065","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/jphysiol.2010.190298","article-title":"Patient autoantibodies deplete postsynaptic Muscle Specific Kinase leading to disassembly of the ACh receptor scaffold and myasthenia gravis in mice","volume":"588","author":"Cole","year":"2010","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","article-title":"The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo","volume":"85","author":"DeChiara","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1113\/jphysiol.2008.167387","article-title":"Reporting ethical matters in The Journal of Physiology: standards and advice","volume":"587","author":"Drummond","year":"2009","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0080","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0085","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0090","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/mus.20491","article-title":"Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis","volume":"33","author":"Farrugia","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0095","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","article-title":"Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures","volume":"185","author":"Farrugia","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0100","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nn1071","article-title":"Postsynaptic requirements for Abl kinases in assembly of the neuromuscular junction","volume":"6","author":"Finn","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/377232a0","article-title":"Failure of postsynaptic specialization to develop at neuromuscular junctions of rapsyn deficient mice","volume":"377","author":"Gautam","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0092-8674(00)81253-2","article-title":"Defective neuromuscular synaptogenesis in agrin-deficient mutant mice","volume":"85","author":"Gautam","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ydbio.2007.02.008","article-title":"Developmental increase in the amount of rapsyn per acetylcholine receptor promotes postsynaptic receptor packing and stability","volume":"305","author":"Gerv\u00e1sio","year":"2007","journal-title":"Dev. Biol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","article-title":"Muscle Specific Kinase: Organiser of synaptic membrane domains","volume":"43","author":"Ghazanfari","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0125","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1113\/jphysiol.2013.270207","article-title":"Muscle Specific Kinase autoantibodies suppress the MuSK pathway and ACh receptor retention at the mouse neuromuscular junction","volume":"592","author":"Ghazanfari","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0130","doi-asserted-by":"crossref","first-page":"e87840","DOI":"10.1371\/journal.pone.0087840","article-title":"Effects of the \u03b22-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis","volume":"9","author":"Ghazanfari","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0135","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3109\/08916930903555943","article-title":"Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction","volume":"43","author":"Gomez","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","article-title":"Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts","volume":"44","author":"Guptill","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0145","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.mcn.2005.10.020","article-title":"Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK","volume":"31","author":"Hesser","year":"2006","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0150","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.0954-6820.1956.tb14351.x","article-title":"The isolation of gamma globulin from blood-serum by rivanol","volume":"155","author":"Horejsi","year":"1956","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0160","doi-asserted-by":"crossref","first-page":"20783","DOI":"10.1073\/pnas.1313944110","article-title":"MuSK IgG4 auto-antibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4","volume":"110","author":"Huijbers","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0165","doi-asserted-by":"crossref","first-page":"ra7","DOI":"10.1126\/scisignal.2000113","article-title":"Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation","volume":"2","author":"Inoue","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jneuroim.2006.03.016","article-title":"Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK)","volume":"175","author":"Jha","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0175","article-title":"Guanidine and neuromuscular transmission. II. Effect on transmitter release in response to repetitive nerve stimulation","volume":"32","author":"Kamenskaya","year":"1975","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0b013e318237f660","article-title":"Anti-MuSK autoantibodies block binding of collagen Q to MuSK","volume":"77","author":"Kawakami","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0185","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0190","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nn2026","article-title":"MuSK controls where motor axons grow and form synapses","volume":"11","author":"Kim","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0195","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","article-title":"Lrp4 is a receptor for agrin and forms a complex with MuSK","volume":"135","author":"Kim","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0200","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/brain\/aws025","article-title":"Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice","volume":"135","author":"Klooster","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0205","doi-asserted-by":"crossref","first-page":"e80695","DOI":"10.1371\/journal.pone.0080695","article-title":"MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters","volume":"11","author":"Koneczny","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0210","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.embor.7400065","article-title":"Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference","volume":"5","author":"Kong","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","article-title":"A call for transparent reporting to optimize the predictive value of preclinical research","volume":"490","author":"Landis","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0220","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1093\/brain\/awh612","article-title":"Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis","volume":"128","author":"Losen","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3109\/17482960903545334","article-title":"Guidelines for preclinical animal research in ALS\/MND: a consensus meeting","volume":"11","author":"Ludolph","year":"2010","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2990.2008.00965.x","article-title":"Muscle histopathology in myasthenia gravis with antibodies against MuSK and AChR","volume":"35","author":"Martignago","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0235","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","article-title":"Detection and characterization of MuSK antibodies in seronegative myasthenia gravis","volume":"55","author":"McConville","year":"2004","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0240","doi-asserted-by":"crossref","first-page":"7841","DOI":"10.1128\/MCB.24.18.7841-7854.2004","article-title":"A single pulse of agrin triggers a pathway that acts to cluster acetylcholine receptors","volume":"24","author":"Mittaud","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0260","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.autrev.2013.03.005","article-title":"Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis","volume":"12","author":"Mori","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0245","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jneuroim.2012.02.010","article-title":"3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis","volume":"245","author":"Mori","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0250","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.ajpath.2011.10.031","article-title":"Antibodies against Muscle-Specific Kinase impair both presynaptic and postsynaptic functions in a murine model of myasthenia gravis","volume":"180","author":"Mori","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jneuroim.2011.12.005","article-title":"Divalent and monovalent autoantibodies cause dysfunction of MuSK by distinct mechanisms in a rabbit model of myasthenia gravis","volume":"244","author":"Mori","year":"2012","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.expneurol.2012.06.034","article-title":"Muscle Specific Kinase autoantibodies cause synaptic failure through progressive wastage of postsynaptic acetylcholine receptors","volume":"237","author":"Morsch","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0270","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1113\/jphysiol.2013.251827","article-title":"Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by Muscle Specific Kinase autoantibody","volume":"591","author":"Morsch","year":"2013","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0275","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","article-title":"Myasthenia gravis without acetylcholine receptor antibody: a distinct disease entity","volume":"327","author":"Mossman","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0280","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/awm068","article-title":"Phenotypical spectrum of DOK7 mutations in congenital myasthenic syndromes","volume":"130","author":"M\u00fcller","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0285","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1097\/00001756-200411150-00014","article-title":"Neuregulin potentiates agrin-induced acetylcholine receptor clustering in myotubes","volume":"15","author":"Ngo","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/mus.21642","article-title":"Pre- and postsynaptic neuromuscular junction abnormalities in MuSK myasthenia","volume":"42","author":"Niks","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0295","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1471-4159.2011.07216.x","article-title":"Tetanic failure due to decreased endogenous adenosine A2A tonus operating neuronal Cav1 (l-type) influx in Myasthenia gravis","volume":"117","author":"Noronha-Matos","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0300","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.neulet.2010.07.076","article-title":"The effects of anesthesia on measures of nerve conduction velocity in male C57Bl6\/J mice","volume":"483","author":"Oh","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0305","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1086\/339465","article-title":"Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome","volume":"70","author":"Ohno","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0310","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1468-1331.2007.01870.x","article-title":"Clinical and experimental features of MuSK antibody positive MG in Japan","volume":"14","author":"Ohta","year":"2007","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0315","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.1127142","article-title":"The muscle protein Dok-7 is essential for neuromuscular synaptogenesis","volume":"312","author":"Okada","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0320","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/brain\/awm072","article-title":"Clinical features of the DOK7 neuromuscular junction synaptopathy","volume":"130","author":"Palace","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0325","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/mus.21533","article-title":"Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience","volume":"41","author":"Pasnoor","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0330","doi-asserted-by":"crossref","first-page":"e110571","DOI":"10.1371\/journal.pone.0110571","article-title":"Altered active zones, vesicle pools, nerve terminal 1 conductivity, and morphology during experimental MuSK myasthenia gravis","volume":"9","author":"Patel","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0335","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.expneurol.2011.04.018","article-title":"Muscle-selective synaptic disassembly and reorganization in MuSK antibody-positive MG mice","volume":"230","author":"Punga","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0340","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/WCO.0000000000000136","article-title":"Clinical and scientific aspects of MuSK-related myasthenia gravis","volume":"27","author":"Reddel","year":"2014","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0345","first-page":"453","article-title":"Acute severe animal model of anti-Muscle-specific kinase myasthenia","volume":"69","author":"Richman","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0350","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.clinph.2006.03.028","article-title":"Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes","volume":"117","author":"Rostedt Punga","year":"2006","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0355","doi-asserted-by":"crossref","first-page":"e46663","DOI":"10.1371\/journal.pone.0046663","article-title":"Agrin and synaptic laminin are required to maintain adult neuromuscular junctions","volume":"7","author":"Samuel","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0360","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/01.WNL.0000128048.23930.1D","article-title":"Are MuSK antibodies the primary cause of myasthenic symptoms?","volume":"62","author":"Selcen","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0365","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1172\/JCI21545","article-title":"Induction of myasthenia by immunization against muscle-specific kinase","volume":"116","author":"Shigemoto","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0370","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ana.20341","article-title":"Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis","volume":"57","author":"Shiraishi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0375","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/brain\/115.2.451","article-title":"Structure and function of neuromuscular junctions in the vastus lateralis of man","volume":"115","author":"Slater","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0380","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.psyneuen.2013.05.011","article-title":"Acute restraint stress induces rapid and prolonged changes in erythrocyte and hippocampal redox status","volume":"38","author":"Spiers","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0390","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/0023677214541438","article-title":"Manual versus automated blood sampling: impact of repeated blood sampling on stress parameters and behavior in male NMRI mice","volume":"48","author":"Teilmann","year":"2014","journal-title":"Lab. Anim."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0395","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2353\/ajpath.2009.090040","article-title":"The effect of plasma from muscle-specific tyrosine kinase myasthenia gravis patients on regenerating endplates","volume":"175","author":"ter Beek","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0400","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0969-2126(02)00814-6","article-title":"Crystal structure of the MuSK tyrosine kinase insights into receptor autoregulation","volume":"10","author":"Till","year":"2002","journal-title":"Structure"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0405","first-page":"e52220","article-title":"The neuromuscular junction: measuring synapse size, fragmentation and changes in synaptic protein density using confocal fluorescence microscopy","volume":"94","author":"Tse","year":"2014","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0410","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.clim.2014.02.012","article-title":"Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice","volume":"151","author":"Ulusoy","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0415","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2012.01.025","article-title":"Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects","volume":"234","author":"Viegas","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0420","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0425","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1113\/jphysiol.1997.sp022007","article-title":"The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles","volume":"500","author":"Wood","year":"1997","journal-title":"J. Physiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0430","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2014.12.013_bb0435","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im1508s100","article-title":"Experimental autoimmune myasthenia gravis in the mouse","author":"Wu","year":"2013"},{"key":"10.1016\/j.expneurol.2014.12.013_bb0440","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","article-title":"LRP4 serves as a coreceptor of agrin","volume":"60","author":"Zhang","year":"2008","journal-title":"Neuron"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614003987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488614003987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T14:52:13Z","timestamp":1537973533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488614003987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":87,"alternative-id":["S0014488614003987"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.12.013","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines for pre-clinical animal and cellular models of MuSK-myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2014.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}